Low prevalence of latex sensitivity in South African spina bifida children in Cape Town

Pediatric Allergy and Immunology

Volumn 16, Issue 2, 2005, Pages 165-170

  Johar, Asmah ^a,b   Lim, Dawn L ^c   Arif, Siti Arija Mad ^d   Hawarden, Di ^e   Du Toit, George ^e   Weinberg, Eugene G ^e   Motala, Gas ^e   Fieggen, G ^e   Yeang, Hoong Yeet ^d   Potter, Paul C ^b  

^a HOSPITAL KUALA LUMPUR   (Malaysia)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d RUBBER RESEARCH INSTITUTE OF MALAYSIA   (Malaysia)

^e RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

Children; Hev b1; Hev b3; Latex allergy; Spina bifida

Indexed keywords

LATEX; PROTEIN; PROTEIN HEV B1; PROTEIN HEV B3; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGY; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOALLERGOSORBENT TEST; SENSITIZATION; SKIN TEST; SOCIAL STATUS; SOCIOECONOMICS; SOUTH AFRICA; SPINA BIFIDA; WESTERN BLOTTING;

EID: 20144389159     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2005.00221.x     Document Type: Article

References (23)

1. TURJANMAA K, ALENIUS H, MAKINEN-KILJUNEN S, RUNALA T, PALSOVO T. Natural rubber latex allergy. Allergy 1996: 51: 593-602.
2. POTTER PC. CROMBIE I, MARION A, KOSHEVA O, MAQULA B, SCHINKEL M. Latex allergy at Groote Schuur Hospital: prevalence, clinical features and the outcome. S Afr Med J 2001: 91: 760-5.
3. HASMA H, SHAHNAZ M, YIP E, AZIZAH M, MOK KL, NASARUDDIN BA. Binding patterns of IgE antibodies in sera of rubber tappers to fresh Hevea latex serum proteins. J Rubb Res 1998: 1: 146-53.
4. NASARUDDIN BA, SHAHNAZ M, AZIZAH MR, HASMAH H, MOK KL, HIP E. Prevalence Study of Type 1 Latex Hypersensitivity Among High Risk Groups in the Malaysian Population. A Preliminary Report. Kuala Lumpur, Malaysia: Workshop on Latex Protein Allergy, 1994.
5. CHAIEAR N, SADJRA S, JONES M, CULLINAN P, FOULDS IS, BURGE PS. Sensitization to natural rubber latex: an epidemiological study of workers exposed during tapping and glove manufacture in Thailand. Occup Environ Med 2001: 58: 386-91.
6. YASSIN M, SANYURAH S, LIERL MB, et al. Evaluation of latex allergy in patients with meningomyelocele. Ann Allergy 1992: 69: 207-11.
7. KELLY KJ, KURUP V, ZACHARISEN M, RESNICK A, FINK JN. Skin and serologic testing in the diagnosis of latex allergy. J Allergy Clin Immunol 1993: 91: 1140-5.
8. MONERET-VAUTRIN DA, BEAUDOUIN E, WIDMER S, et al. Prospective study of risk factors in natural rubber latex hypersensitivity. J Allergy Clin Immunol 1993: 92: 668-77.
9. NIGGEMANN MT, MOERS A, SEIDEL U, WAHN U, SCHENER D. Risk factors for latex allergy in patients with spina bifida. Clin Exp Allergy 1996: 26: 934-9.
10. NIETO A, ESTORNELL F, MAZON A, REIG C, GARCIA-IBARRA F. Allergy to latex in spina bifida: a multivariate study of associated factors in 100 consecutive patients. J Allergy Clin Immunol 1996: 100: 501-7.
11. FRANKLAND AW. Latex allergy in children. Paediatr Allergy Immunol 1999: 10: 152-9.
12. BENARDINI R, NOVEMBRE E, LOMBARDI E, et al. Prevalence and risk factors for latex sensitization in patients with spina bifida. J Urol 1998: 160: 1775-8.
13. CAPRILES-HULETT A, SANCHEZ-BORGES M, VON -SCANZONI C, MEDINA JR. Very low frequency of latex and fruit allergy in patients with spina bifida from Venezuela: influence of socioeconomic factors. Ann Allergy Asthma Immunol 1995: 75: 62-4
14. YEANG HY, CHEONG KF, SUNDERASAN E, et al. The 14.6 kd rubber elongation factor (Hev b1) and the 24 kd (Hev b3) rubber particle proteins are recognized by IgE from patients with spina bifida and latex allergy. J Allergy Clin Immunol 1996: 98: 628-39.
15. RUE F, KIENITZ A, SCHOPF P, et al. Frequency of natural rubber latex allergy in adults is increase in those with multiple operative procedures. Allergy 2001: 569: 889-94.
16. HSIA RCH. Oxygen absorption by Hevea brasiliensis latex. Institution of the Rubber Industry: Transactions and Proceedings, 1958: 34: 267-90.
17. MOIR GFJ. Utracentrifugation and staining of Hevea latex. Nature (Lond) 1959: 184: 626-8.
18. LAEMLII UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970: 277: 680-5.
19. MOTULSKY H. Intuitive Biostatistics. New York, Oxford: Oxford University Press, 1995.
20. CREMER R, KLEINE-DIEPENBRUCK U, BLAKER F. Latex allergy in spina bifida patients. Prevention by primary prophylaxis. Allergy 1998: 53: 709-71.
21. BOWMAN RM, MC LORE DG, GRANT JA, TOMITA T, ITO JA. Spina bifida outcome: a 25 year prospective. Pediatr Neurosurg 2001: 349: 141-20.
22. BENARDINI R, NOVENBER E, LOMBARDI E, et al. Risk factors for latex allergy in patients with spina bifida and latex sensitization. Clin Exp Allergy 1999: 29: 681-6.
23. HEINMAN HA. DONSAN H, KAWALSKI M, TOERIEN A, POTTER PC. Bronchial hyper-responsiveness and atopy in urban, peri urban and rural South African children. Paediatr Allergy Immunol 2003: 14: 383-93.